PNC Financial Services Group
SLDB icon

PNC Financial Services Group’s Solid Biosciences SLDB Stock Holding History

PNC Financial Services Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.81K Hold
682
– – ﹤0.01% 4272
2026
Q1 		$4.91K Buy
682
+26
+4% +$167 ﹤0.01% 4279
2025
Q4 		$3.7K Sell
656
-128
-16% -$694 ﹤0.01% 4346
2025
Q3 		$4.84K Buy
784
+37
+5% +$216 ﹤0.01% 4222
2025
Q2 		$3.64K Buy
747
+616
+470% +$2.18K ﹤0.01% 4234
2025
Q1 		$485 Buy
+131
New +$561 ﹤0.01% 4650
2020
Q3 		– Sell
-44
Closed -$2K – 4034
2020
Q2 		$2K Buy
+44
New +$1.83K ﹤0.01% 3792

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group's SLDB Position: Q2 2026 in Review

PNC Financial Services Group held its Solid Biosciences (SLDB) position steady in Q2 2026 at 682 shares worth $6.81K. The position accounts for ﹤0.01% of the portfolio, ranked #4272.

PNC Financial Services Group first reported a position in SLDB in Q2 2020 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • PNC Financial Services Group held 682 shares of Solid Biosciences worth $6.81K as of Q2 2026.
  • PNC Financial Services Group left its Solid Biosciences share count unchanged in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4272 holding.
  • PNC Financial Services Group first reported a position in Solid Biosciences in Q2 2020 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.